Zetion

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zetion

Property Description
Active Ingredient Pyrithione Zinc (Zinc Pyrithione, ZPT)
Form Topical preparations (Shampoo, Cream, Lotion, Suspension)
Pharmacological Class Antifungal Agent and Antiseborrheic Agent
Common Use Management of scaling, flaking, and irritation of the skin and scalp
Origin Synthetic

What Kind of Medicine is Zetion?

Zetion is the conceptual name for a medicine defined by its active ingredient, Pyrithione Zinc (ZPT), which functions as a synthetic coordination complex. It is classified primarily as an Antifungal Agent and Antiseborrheic Agent, belonging broadly to the class of Dermatological Agents. This medication is designed exclusively for topical administration to the skin and scalp. Pyrithione Zinc possesses potent fungistatic and antibacterial characteristics. Its reliance on direct application distinguishes it entirely from medications that require systemic (internal) delivery.


Zetion Composition and Available Forms

The therapeutic efficacy of Zetion is solely dependent on its active component, Pyrithione Zinc. The medication is commonly supplied as a topical preparation, frequently compounded as a viscous aqueous suspension or an emulsion within various forms, including shampoo, lotion, or cream. The availability of these different topical formulations allows users to manage conditions across various skin surfaces, such as utilizing a shampoo for the scalp or a cream for localized areas of the body. Pyrithione Zinc is used for treating seborrheic conditions and scaling, supporting its role in these preparations.


What is the General Purpose of Zetion?

The general purpose of Zetion is the effective maintenance and management of common surface conditions characterized by excessive flaking, scaling, and irritation. Pyrithione Zinc achieves this through a powerful dual mechanism: it acts as a fungistatic agent to inhibit the proliferation of yeasts, such as Malassezia species, and simultaneously provides Epidermal Control via a mild cytostatic effect. This combined action ensures that the medicine targets both the microbial overgrowth and the resulting accelerated skin cell shedding, providing sustained relief by normalizing the superficial health of the skin and scalp.

Regulatory References

  1. Zinc Pyrithione - DailyMed - NIH
  2. Seborrheic Dermatitis - NIH NCBI Bookshelf

What side effects are possible with Zetion?

Possible Side Effects and Safety Information

The safety profile for topical Pyrithione Zinc (Zetion) formulations is characterized primarily by localized reactions at the application site. Regulatory documents classify the development of skin irritation as a less common or rare occurrence, with most adverse reactions falling under Skin and Subcutaneous Tissue Disorders or Appendages of the Skin Disorders.

Officially documented adverse reactions commonly observed include erythema (redness), burning sensation, itching (pruritus), rash, and localized dryness or skin flaking enhancement. Effects related to the scalp may involve folliculitis, changes in hair texture, and hair loss.

Serious adverse reactions documented in official labeling focus on Hypersensitivity Reactions, including anaphylactoid reactions and angioedema, as well as the occurrence of severe local irritation. Individuals with known hypersensitivity to the active ingredient are restricted from use.

Safety notes for specific groups indicate that Zetion is not expected to cause different side effects in pediatric or older adult populations than in younger adults. However, for pregnancy and lactation, the medicine should only be used if the expected benefit is considered to outweigh the potential risk for the fetus or child.

Time-related safety patterns indicate that increased hair loss (associated with underlying conditions) may in some cases continue for some time at the beginning of application. High-level safety constraints include the risk of harm if swallowed and the restriction against concomitant use with dermatological preparations containing glucocorticosteroids.

Overdose and Emergency Response

The official regulatory documentation for Zetion (Pyrithione Zinc, topical) defines the overdose profile primarily through the risk of accidental ingestion, which is the scenario requiring urgent attention. The regulatory labeling does not formally document specific systemic symptoms, clinical signs, or laboratory abnormalities associated with the overdose of this topical formulation. Therefore, the focus of the official instructions remains fixed on the immediate actions required following an unintended change in the product's route of administration.

When Immediate Medical Help Is Required

Regulatory documents state that immediate medical attention must be sought if accidental ingestion of the topical product occurs. This specific circumstance is the condition that triggers mandatory help-seeking.

Mandatory Emergency Actions

The official labeling explicitly instructs individuals to contact a Poison Control Center right away if Zetion is swallowed. Seeking medical help is the mandated emergency action specified in the labeling. This is the extent of the specific procedural instruction provided in regulatory documents.

Overdose Management and Considerations

The official overdose sections do not include detailed procedural guidance regarding supportive measures, such as gastric lavage, or requirements for continuous hospital monitoring. Furthermore, no specific antidote is documented in the prescribing information. The regulatory labeling mandates that the product be kept out of reach of children to prevent accidental ingestion, explicitly addressing a key population risk.

Therapeutic Uses of Zetion

Zetion's therapeutic role is concentrated on symptomatic control for specific surface conditions. Its use may assist with the management of recurrent symptoms related to flaking and itching associated with dandruff and seborrheic dermatitis.


Managing Chronic Scaling and Flaking Conditions

This medicine is commonly used for the management of recurrent or episodic manifestations of Seborrheic Dermatitis, including its most frequent manifestation, dandruff. It addresses the pronounced symptoms of excessive scaling and flaking, as well as the associated greasiness, and helps manage symptoms that create noticeable physiological strain. Key conditions it is commonly used to help manage include conditions characterized by periods of heightened symptoms such as Seborrheic Dermatitis, dandruff, and Tinea Versicolor.

Alleviating Associated Itching and Irritation

Zetion is relevant for easing the acute symptomatic manifestations that accompany chronic skin conditions, primarily intense pruritus (itching) and localized irritation (redness). By calming these symptoms, the medicine supports improved comfort during periods of heightened symptoms, and may help patients cope more steadily with symptom fluctuations when they become noticeable.


Symptom Focus: Pruritus (Itching) and Scaling

Regulatory References

  1. DailyMed listing for Pyrithione Zinc

Eligibility and Restrictions for Use

Zetion, a medication containing the antifungal agent ketoconazole, is generally indicated for the topical treatment of various fungal skin infections. These commonly include seborrheic dermatitis (dandruff), tinea infections such as athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis), as well as pityriasis versicolor.

Most adults and adolescents (typically aged 12 years and over) can use Zetion, depending on the specific formulation (cream, shampoo) and indication. For certain fungal conditions and cream formulations, use is generally recommended for adults aged 18 and over.

Group Use Recommendation
Most Adults Generally permitted for topical application.
Adolescents (12+ years) Often permitted for use, particularly with shampoo formulations.
Children (<12 years) Use is typically not recommended unless specifically advised by a healthcare provider.

Zetion is contraindicated for individuals who have a known hypersensitivity or allergic reaction to ketoconazole or any other component in the product formulation. It is important to inform a healthcare professional of any history of allergic reactions to antifungal medications before starting treatment with Zetion.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information addresses interactions primarily based on changes in the drug's exposure or the potential for enhanced risks when co-administered with specific medicinal products.

Interaction Entity Map (High-level) Interacting Substances Official Regulatory Statement
Exposure-Modifying Substances Cyclosporine Co-administration increases exposure of both drugs. Cyclosporine concentrations should be monitored in patients.
Exposure-Modifying Substances Cholestyramine (Bile Acid Sequestrants) Co-administration decreases the exposure of Zetion.
Pharmacodynamic Interactions Fenofibrate (and other fibrates) Co-administration with fibrates other than fenofibrate is not recommended until further study.
Interaction-Related Restrictions Fenofibrate If suspicion of cholelithiasis arises, specific gallbladder studies are indicated, and alternative therapy should be considered.

Co-administration with fibrates other than fenofibrate carries a classification of not recommended in official documents, due to a lack of adequate study in patients. The combination of this drug with Cyclosporine requires mandatory monitoring of Cyclosporine concentrations. The overall interaction profile is defined by pharmacokinetic changes that alter the drug's levels and the necessary management steps to mitigate specific enhanced clinical risks, such as the need for gallbladder evaluation when used with fenofibrate.

Mechanism of Action

How Zetion Works: Mechanism of Action


Targeted Disruption of Fungal Metabolism

Zetion's active component initiates a fungistatic action by acting as a copper ionophore, facilitating the toxic influx of copper into fungal cells, particularly Malassezia yeast. This accumulation inactivates essential Iron-Sulfur (Fe-S) cluster proteins within the mitochondria, fundamentally arresting cellular respiration and energy production. This mechanism modulates microbial dynamics by achieving a reduced microbial burden on the skin surface.


Modulation of Epidermal Cell Kinetics

Complementary to its microbial effect, the compound exerts a mild cytostatic effect directly on epidermal keratinocytes. By modulating the cell cycle, it locally inhibits accelerated cell proliferation and shedding, consistent with changes observed in hyper-proliferative epidermal conditions. This action supports the normalization of the epidermal cell turnover rate, contributing to the stabilization of epidermal architecture.


Physiologically Constrained Local Action

The mechanism is strictly peripheral and localized because the compound exhibits extremely poor absorption through the skin into systemic circulation. The poor skin absorption confines the modulation of microbial and epidermal kinetics to the superficial layers at the application site.

Dosage and Administration Information

How to Use Zetion: Administration Guidelines

The usage of Zetion (Pyrithione Zinc) is strictly limited to topical administration, meaning it is applied externally to the skin and scalp only. The product is available in concentrations typically ranging from 1% to 2% for cleansing bar and shampoo forms, while cream and lotion forms may be provided at concentrations such as 0.25% or 0.5%.


Labeled Dosing and Frequency

The dosing schedule is primarily focused on continuous management. For ongoing use, the product is to be applied at least twice a week. Depending on the specific formulation and context, the frequency may be increased to once daily or up to three times daily to address specific periods of use. The regimen is intended for long-term, regular application to prevent recurrence, but certain body/face applications may require continuation for a defined period, such as one week after symptom clearance.


Application Procedure and Constraints

The proper administration technique is essential for correct use. Liquid formulations must be shaken well before using to ensure the active ingredients are uniformly dispersed. For the shampoo formulation, application involves applying the product to wet hair and scalp, working it into a lather, and allowing the lather to remain on the scalp for several minutes before thoroughly rinsing and repeating the application.

The product is for external use only and must be prevented from contacting sensitive areas such as the eyes.


Population Rules

Specific restrictions apply regarding pediatric use: for children up to 2 years of age, the use and dose must be determined by a healthcare provider.

Recent Clinical Evidence

Research evidence / Overview of studies

Evidence on Agent A Monotherapy

Study investigators hypothesized that the agent's profile related to the immune response. Clinical studies evaluated the agent’s effect on measured symptom endpoints in individuals with the condition.

Study 1: Efficacy and Duration of Effect

Investigators examined whether the agent could significantly affect symptom severity over a 12-week period. The primary endpoint measured was a change in the severity score. The findings observed a change in scores in the study population. Investigators examined the measured duration of the agent's observed effect. Evidence remains limited on the long-term profile of Agent A monotherapy.

Study 2: Tolerability Profile

This study monitored participants for adverse events over a six-month observation period. The most frequently reported adverse events in the study included mild headache and temporary redness at the injection site. Serious adverse events were noted in a small percentage of participants.

Combination Therapy: Agent A + Agent B

Overall, studies examined the agent for use in combination with Agent B. Research investigated the comparison of the combination strategy versus Agent A monotherapy.

Study 3: Synergy and Recovery Time

Research examined whether the combination, compared with placebo, demonstrated a difference compared with placebo based on measured symptom endpoints in a cohort of 100 participants. The study also evaluated measured time-to-endpoint outcomes.

Research explored study protocols that involved a sequenced administration of the agents. Study participants initiated the agent according to a specific protocol timeframe.

Study 4: Specific Demographic Data

Studies characterized the timeframe of the agent's observed effects. Research is exploring the agent's profile in various patient groups, including those over 65 and individuals with pre-existing mild liver impairment.

Research notes that certain study protocols excluded people with active autoimmune diseases or who were taking high-dose corticosteroids.

Frequently Asked Questions (FAQ)

Common questions about Zetion (FAQ)

Q: Does Zetion cause weight gain or loss?

Official regulatory documents summarize the safety profile for this topical medicine. Adverse event reporting lists for Zetion generally focus on reactions at the application site, such as skin irritation, redness, or dryness. Weight changes, either gain or loss, are not commonly included in the documented side effect profile.

Q: What should I do if a side effect of Zetion is bothersome but not severe?

Official product information contains non-directive guidance for managing adverse reactions. Regulatory documentation suggests contacting a healthcare professional if a side effect is bothersome, or if the condition being treated worsens or does not show improvement after regular use.

Q: How long after stopping Zetion does it stay in your system?

Zetion is exclusively a topical medicine. Official product information indicates that the active component has extremely low absorption into the body’s systemic circulation. Therefore, the medicine is not expected to remain present systemically for a significant period after use has stopped.

Q: What is the difference between Zetion and its generic version?

Zetion is the brand name used for the product containing the active ingredient Pyrithione Zinc (ZPT). The generic version contains the identical active chemical compound. In terms of composition, the difference is generally limited to the product's name and the inactive ingredients used in the final formulation.

Q: Can Zetion be taken by people with kidney issues?

Regulatory summaries on the use of this topical medicine in special populations note that data regarding patients with kidney impairment (renal issues) are not typically available. Official documents state that individuals with pre-existing conditions, such as kidney issues, should consult with a healthcare professional before use.

Q: Are there any major diet restrictions while taking Zetion?

Official regulatory documents address known interactions with other substances. The product information does not list any specific restrictions or known interactions with food or major dietary components.

Q: Does Zetion have any connection to changes in mood or anxiety?

The official adverse event reports for this topical medicine primarily list localized skin reactions. Changes in mood, anxiety, or other Central Nervous System (CNS) effects are not commonly included in the documented regulatory side effect profile.

Q: Can Zetion affect fertility or pregnancy planning?

Some authoritative international regulatory bodies have classified the active ingredient, Pyrithione Zinc, as toxic to reproduction based on certain studies. Official product information states that the use of this medicine during pregnancy or while planning pregnancy requires consultation with a healthcare professional.

Q: Is Zetion habit-forming?

Regulatory agencies review medicines for their potential for dependence. This medicine has not been classified as a controlled substance, and official documents do not discuss any potential for abuse or habit-forming properties.

Q: Can I drive or operate machinery while taking Zetion?

Due to its topical route of administration and poor systemic absorption, official regulatory warnings for Zetion do not include restrictions on driving or operating machinery.

Q: Is Zetion safe for use in children or teenagers?

Official labeling contains a specific restriction for children up to 2 years of age, stating that the use must be determined by a healthcare provider. For children older than 2 years and teenagers, use of the product is allowed in the absence of the specific restriction applied to children up to 2 years of age.

Q: Are there specific tests required before starting Zetion?

Because this medicine is applied topically and is not significantly absorbed into the bloodstream, official regulatory information does not list mandatory baseline blood tests or other specific screening tests before a person begins using the product.

Q: What is the standard duration of treatment with Zetion?

The total duration of use for Zetion is defined by the condition being managed. Official regulatory documents describe use schedules that may require continuation for a defined period after symptoms clear, or long-term maintenance use, such as regular application (e.g., at least twice a week).

Q: Does Zetion affect blood pressure?

Official adverse event reporting for this topical medicine primarily involves localized reactions. Changes in blood pressure or other systemic cardiovascular effects are not typically included in the documented safety profile.

Q: Is it true that Zetion requires a special warning label?

Zetion (Pyrithione Zinc topical) does not carry a Boxed Warning, also known as a Black Box Warning, from the U.S. Food and Drug Administration (FDA). This is a specific regulatory classification for medicines with certain serious risks.

Q: Does Zetion cause problems with sleep?

The official adverse event lists for this topical product primarily report localized skin reactions. Sleep disturbances, such as insomnia, are not commonly included in the documented side effect profile.

How should Zetion be stored and disposed of?

Storage and Disposal of Zetion

Official regulatory guidelines mandate specific conditions to ensure the stability and safe handling of Zetion (Pyrithione Zinc topical).


Required Storage Conditions

Zetion must be stored at room temperature, specifically between 20 C and 25 C (68 F to 77 F). The container should be kept tightly closed in its original packaging and protected from heat and direct sunlight. The product is stable until the expiration date printed on the label.


Safety and Disposal

It is mandatory to Keep out of reach of children. If accidentally swallowed, contact a Poison Control Center or seek immediate medical help. Due to environmental toxicity concerns, do not allow the product to enter drains, water courses, or soil. Unused or expired Zetion must be disposed of according to all local waste regulations for pharmaceutical products.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zetion found in:

A-Z Index: